HM00256 | APOA2 | spleen | MESH:D006528 | Carcinoma, Hepatocellular | liver |
HM00256 | APOA2 | spleen | MESH:D056486 | Drug-Induced Liver Injury | |
HM00256 | APOA2 | spleen | MESH:D007333 | Insulin Resistance | |
HM00256 | APOA2 | spleen | MESH:D002252 | Carbon Tetrachloride Poisoning | |
HM00256 | APOA2 | spleen | MESH:D006529 | Hepatomegaly | |
HM00256 | APOA2 | spleen | MESH:D009135 | Muscular Diseases | muscle |
HM00256 | APOA2 | spleen | MESH:D015428 | Myocardial Reperfusion Injury | |
HM00256 | APOA2 | spleen | MESH:D001778 | Blood Coagulation Disorders | bone marrow |
HM00256 | APOA2 | spleen | MESH:D006932 | Hyperbilirubinemia | |
HM00256 | APOA2 | spleen | MESH:D009402 | Nephrosis, Lipoid | kidney |
HM00256 | APOA2 | spleen | MESH:D007638 | Keratoconjunctivitis Sicca | eye |
HM00256 | APOA2 | spleen | MESH:D008325 | Mammary Neoplasms, Experimental | |
HM00256 | APOA2 | spleen | MESH:D003876 | Dermatitis, Atopic | skin |
HM00256 | APOA2 | spleen | MESH:D005833 | Genital Neoplasms, Female | |
HM00256 | APOA2 | spleen | MESH:D006943 | Hyperglycemia | |
HM00256 | APOA2 | spleen | MESH:D007674 | Kidney Diseases | ureter |
HM00256 | APOA2 | spleen | MESH:D007674 | Kidney Diseases | pituitary |
HM00256 | APOA2 | spleen | MESH:D007674 | Kidney Diseases | kidney |
HM00256 | APOA2 | spleen | MESH:D016135 | Spinal Dysraphism | spinal cord |
HM00256 | APOA2 | spleen | MESH:D008106 | Liver Cirrhosis, Experimental | |
HM00256 | APOA2 | spleen | MESH:D010051 | Ovarian Neoplasms | uterus |
HM00256 | APOA2 | spleen | MESH:D010051 | Ovarian Neoplasms | |
HM00256 | APOA2 | spleen | MESH:D014985 | Xerophthalmia | eye |
HM00256 | APOA2 | spleen | MESH:D055371 | Acute Lung Injury | |
HM00256 | APOA2 | spleen | MESH:D000310 | Adrenal Gland Neoplasms | adrenal gland |
HM00256 | APOA2 | spleen | MESH:D000310 | Adrenal Gland Neoplasms | adrenal gland |
HM00256 | APOA2 | spleen | MESH:D006973 | Hypertension | lung |
HM00256 | APOA2 | spleen | MESH:D006973 | Hypertension | heart |
HM00256 | APOA2 | spleen | MESH:D006973 | Hypertension | blood vessel |
HM00256 | APOA2 | spleen | MESH:D005885 | Gingival Hyperplasia | |
HM00256 | APOA2 | spleen | OMIM:143890 | HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT | |
HM00256 | APOA2 | spleen | MESH:D010146 | Pain | |
HM00256 | APOA2 | spleen | MESH:D007248 | Infertility, Male | |
HM00256 | APOA2 | spleen | MESH:D011565 | Psoriasis | skin |
HM00256 | APOA2 | spleen | MESH:D018248 | Adenoma, Liver Cell | |
HM00256 | APOA2 | spleen | MESH:D009436 | Neural Tube Defects | |
HM00256 | APOA2 | spleen | MESH:D009765 | Obesity | |
HM00256 | APOA2 | spleen | MESH:D008107 | Liver Diseases | skin |
HM00256 | APOA2 | spleen | MESH:D008107 | Liver Diseases | muscle |
HM00256 | APOA2 | spleen | MESH:D008107 | Liver Diseases | lung |
HM00256 | APOA2 | spleen | MESH:D008107 | Liver Diseases | liver |
HM00256 | APOA2 | spleen | MESH:D000236 | Adenoma | pancreas |
HM00256 | APOA2 | spleen | MESH:D000236 | Adenoma | liver |
HM00256 | APOA2 | spleen | MESH:D000236 | Adenoma | kidney |
HM00256 | APOA2 | spleen | MESH:D000236 | Adenoma | |
HM00256 | APOA2 | spleen | MESH:D000236 | Adenoma | |
HM00256 | APOA2 | spleen | MESH:D000236 | Adenoma | |
HM00256 | APOA2 | spleen | MESH:D000236 | Adenoma | |
HM00256 | APOA2 | spleen | MESH:D002779 | Cholestasis | liver |
HM00256 | APOA2 | spleen | MESH:D008664 | Metal Metabolism, Inborn Errors | skin |
HM00256 | APOA2 | spleen | MESH:D008664 | Metal Metabolism, Inborn Errors | muscle |
HM00256 | APOA2 | spleen | MESH:D008664 | Metal Metabolism, Inborn Errors | liver |
HM00256 | APOA2 | spleen | MESH:D008664 | Metal Metabolism, Inborn Errors | kidney |
HM00256 | APOA2 | spleen | MESH:D002386 | Cataract | pancreas |
HM00256 | APOA2 | spleen | MESH:D002386 | Cataract | eye |
HM00256 | APOA2 | spleen | MESH:D006333 | Heart Failure | heart |
HM00256 | APOA2 | spleen | MESH:D014581 | Urticaria | skin |
HM00256 | APOA2 | spleen | MESH:D008171 | Lung Diseases | |
HM00256 | APOA2 | spleen | MESH:D002289 | Carcinoma, Non-Small-Cell Lung | lung |
HM00256 | APOA2 | spleen | MESH:D004487 | Edema | |
HM00256 | APOA2 | spleen | MESH:D014652 | Vascular Diseases | spinal cord |
HM00256 | APOA2 | spleen | MESH:D014652 | Vascular Diseases | lung |
HM00256 | APOA2 | spleen | MESH:D014652 | Vascular Diseases | liver |
HM00256 | APOA2 | spleen | MESH:D014652 | Vascular Diseases | kidney |
HM00256 | APOA2 | spleen | MESH:D014652 | Vascular Diseases | blood vessel |
HM00256 | APOA2 | spleen | MESH:D006505 | Hepatitis | |
HM00256 | APOA2 | spleen | MESH:D008546 | Melanoma, Experimental | |
HM00256 | APOA2 | spleen | MESH:D001749 | Urinary Bladder Neoplasms | ureter |
HM00256 | APOA2 | spleen | MESH:D001749 | Urinary Bladder Neoplasms | bladder |
HM00256 | APOA2 | spleen | MESH:D006457 | Hemoglobinuria, Paroxysmal | |
HM00256 | APOA2 | spleen | MESH:D019636 | Neurodegenerative Diseases | nerve |
HM00256 | APOA2 | spleen | MESH:D018246 | Adrenocortical Adenoma | |
HM00256 | APOA2 | spleen | MESH:D008103 | Liver Cirrhosis | liver |
HM00256 | APOA2 | spleen | MESH:D009404 | Nephrotic Syndrome | kidney |
HM00256 | APOA2 | spleen | MESH:D000799 | Angioedema | skin |
HM00256 | APOA2 | spleen | MESH:D005234 | Fatty Liver | |
HM00256 | APOA2 | spleen | MESH:D006689 | Hodgkin Disease | |
HM00256 | APOA2 | spleen | MESH:D001943 | Breast Neoplasms | breast |
HM00256 | APOA2 | spleen | MESH:D008545 | Melanoma | eye |
HM00256 | APOA2 | spleen | MESH:D008545 | Melanoma | cervix |
HM00256 | APOA2 | spleen | MESH:D008545 | Melanoma | bone |
HM00256 | APOA2 | spleen | MESH:D011014 | Pneumonia | lung |
HM00256 | APOA2 | spleen | MESH:D005355 | Fibrosis | |
HM00256 | APOA2 | spleen | MESH:D002583 | Uterine Cervical Neoplasms | cervix |
HM00256 | APOA2 | spleen | MESH:D009374 | Neoplasms, Experimental | |
HM00256 | APOA2 | spleen | MESH:D002294 | Carcinoma, Squamous Cell | lung |
HM00256 | APOA2 | spleen | MESH:D002294 | Carcinoma, Squamous Cell | liver |
HM00256 | APOA2 | spleen | MESH:D002294 | Carcinoma, Squamous Cell | larynx |
HM00256 | APOA2 | spleen | MESH:D002294 | Carcinoma, Squamous Cell | kidney |
HM00256 | APOA2 | spleen | MESH:D002294 | Carcinoma, Squamous Cell | eye |
HM00256 | APOA2 | spleen | MESH:D008113 | Liver Neoplasms | |
HM00256 | APOA2 | spleen | MESH:D008113 | Liver Neoplasms | |
HM00256 | APOA2 | spleen | MESH:D002471 | Cell Transformation, Neoplastic | |
HM00256 | APOA2 | spleen | MESH:D050171 | Dyslipidemias | |
HM00256 | APOA2 | spleen | MESH:D017093 | Liver Failure | |
HM00256 | APOA2 | spleen | MESH:D008175 | Lung Neoplasms | lung |
HM00256 | APOA2 | spleen | MESH:D012878 | Skin Neoplasms | |
HM00256 | APOA2 | spleen | MESH:D016410 | Lymphoma, T-Cell, Cutaneous | |
HM00256 | APOA2 | spleen | MESH:D009369 | Neoplasms | spleen |
HM00256 | APOA2 | spleen | MESH:D009369 | Neoplasms | bone marrow |
HM00256 | APOA2 | spleen | MESH:D056487 | Drug-Induced Liver Injury, Chronic | liver |
HM00256 | APOA2 | spleen | MESH:D017114 | Liver Failure, Acute | |
HM00256 | APOA2 | spleen | MESH:D008114 | Liver Neoplasms, Experimental | |
HM00256 | APOA2 | spleen | MESH:D001321 | Autistic Disorder | |
HM00256 | APOA2 | spleen | MESH:D006930 | Hyperalgesia | |
HM00256 | APOA2 | spleen | MESH:D014605 | Uveitis | eye |
HM00256 | APOA2 | spleen | MESH:D006967 | Hypersensitivity | bone marrow |
HM00256 | APOA2 | spleen | MESH:D009203 | Myocardial Infarction | heart |
HM00256 | APOA2 | spleen | MESH:D011471 | Prostatic Neoplasms | prostate |
HM00256 | APOA2 | spleen | MESH:D015427 | Reperfusion Injury | |